Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × abemaciclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 12 Neoplasm Metastasis 4 Prostatic Neoplasms 3 Glioma 3 Brain Neoplasms 3 Sarcoma, Ewing 2 Recurrence 2 Neoplasms 2 Meningioma 2 Glioblastoma 2 Endometrial Neoplasms 2 Unilateral Breast Neoplasms 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Pathologic Complete Response 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasm, Residual 1 Multiple Myeloma 1 Medulloblastoma 1 Malignant Neoplasms of Female Genital Organs 1 Lymphoma, Non-Hodgkin 1 Liver Metastases From Colorectal Cancer (mCRC) 1 Liposarcoma 1 Leiomyosarcoma 1 Hemangiosarcoma 1

Interventions

Rituximab 15 CT-P10 6 ibrutinib 5 Magnetic Resonance Spectroscopy 5 Cyclophosphamide 5 zanubrutinib 4 venetoclax 4 pirtobrutinib 4 glofitamab 4 fludarabine 4 Lenalidomide 4 acalabrutinib 3 Specimen Handling 3 Bendamustine Hydrochloride 3 obinutuzumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Stem Cell Transplantation 2 Cytarabine 2 Cyclosporine 2 Biopsy 2 voruciclib 1 treosulfan 1 tislelizumab 1 palbociclib 1 ixazomib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Watchful Waiting 1 Vincristine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡